AI assistant
Grounded Lithium Corp. — Board/Management Information 2020
Feb 6, 2020
43625_rns_2020-02-06_9d0f9035-d6c4-4ce9-8be2-464eae2bb59b.pdf
Board/Management Information
Open in viewerOpens in your device viewer
FORM 51-102F3
MATERIAL CHANGE REPORT
Item 1 Name and Address of Company
Canadian International Pharma Corp. 2489 Bellevue Avenue West Vancouver, British Columbia V7V 1E1
(the “Company” or “CIPC”)
Item 2 Date of Material Change
February 6, 2020
Item 3 News Release
Issued in West Vancouver, B.C. on February 6, 2020 and disseminated through the facilities of Market News and Stockwatch.
Item 4 Summary of Material Change
Canadian International Pharma Corp. announces director and officer changes.
Item 5 Full Description of Material Change
5.1 Full Description of Material Change
CIPC announces that Sead Hamzagic has resigned as a director and as the Chief Financial Officer of the Company.
The Company would like to thank Sead Hamzagic for his considerable efforts and dedication and to wish him well in his future endeavours. Mr. Hamzagic has indicated that he may be available to provide certain accounting services to the Company in the future on a paid consulting basis.
For further information, contact Douglas L. Mason at 604-922-2030.
5.2 Disclosure for Restructuring Transactions
Not Applicable.
Item 6 Reliance on subsection 7.1(2) of National Instrument 51-102
Not applicable
Item 7 Omitted Information
No information has been intentionally omitted from this form.
Item 8 Executive Officers
The name and business telephone number of an executive officer of the Corporation who is knowledgeable about the material change and this report is:
Douglas L. Mason, CEO Telephone: (604) 922-2030
Further information may be obtained from Valerie Samson, Corporate Affairs at (604) 922-2030.
Item 9 Date of Report
This report is dated the 6th day of February, 2020.